# A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X)

> **NCT03664258** · — · COMPLETED · sponsor: **Cepheid** · enrollment: 852 (actual)

## Conditions studied

- Non-muscle-invasive Bladder Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Xpert Bladder Cancer Monitor

## Key facts

- **NCT ID:** NCT03664258
- **Lead sponsor:** Cepheid
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-06
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-01-31
- **Target enrollment:** 852 (ACTUAL)
- **Last updated:** 2023-02-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03664258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03664258, "A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03664258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*